Actionnariat et activité des initiés pour Kodiak Sciences Inc. (KOD): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $32.77 |
| Capitalisation | $2.1B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-15 | BORGESON JOHN A. | A-Award | 66,500 | $2.8M |
| 2026-07-15 | PERLROTH VICTOR | A-Award | 100,000 | $4.2M |
| 2026-06-30 | Yang Taiyin | A-Award | 17,731 | $691K |
| 2026-06-30 | PROFUSEK ROBERT | A-Award | 17,731 | $691K |
| 2026-06-30 | Levy Richard S | A-Award | 17,731 | $691K |
| 2026-06-30 | Dahiyat Bassil I | A-Award | 17,731 | $691K |
| 2026-06-30 | Bancroft Charles A | A-Award | 17,731 | $691K |
| 2026-06-30 | BAKER BROS. ADVISORS LP | A-Award | 17,731 | $691K |
| 2026-06-04 | BORGESON JOHN A. | M-Exempt | 30,000 | $31K |
| 2026-06-04 | BORGESON JOHN A. | S-Sale | 25,896 | $881K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $9.6M | $1.4M | $88.3M | $211.8M | $944.4M | $731.5M | $190.4M | $285.5M | $168.1M | $209.9M |
| Placements à Court Terme | 0 | 0 | 0 | $124.7M | $24.6M | 0 | $288.5M | 0 | 0 | 0 |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $10.2M | $1.6M | $90.4M | $339.2M | $972.0M | $734.8M | $486.0M | $289.3M | $171.9M | $214.8M |
| Immobilisations Corporelles | $1.8M | $1.5M | $1.1M | $2.8M | $78.8M | $108.1M | $115.8M | $175.0M | $148.7M | $121.9M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $12.1M | $3.2M | $92.2M | $358.9M | $1.07B | $904.2M | $666.6M | $479.4M | $335.6M | $351.5M |
| Dettes Fournisseurs | $1.1M | $3.4M | $1.1M | $2.6M | $8.6M | $12.4M | $9.1M | $13.6M | $3.9M | $12.9M |
| Dette à Court Terme | 0 | 0 | 0 | $434000 | 0 | $3.9M | $9.9M | $9.8M | 0 | $12.1M |
| Passifs Courants | $2.5M | $9.2M | $4.8M | $11.7M | $31.4M | $64.7M | $52.5M | $41.7M | $25.6M | $45.5M |
| Dette à Long Terme | 0 | $10.0M | 0 | 0 | 0 | $99.9M | $100.0M | $100.0M | 0 | $100.0M |
| Passifs Totaux | $53.2M | $72.0M | $5.4M | $13.5M | $206.6M | $240.9M | $230.5M | $213.6M | $185.3M | $194.2M |
| Réserves | -$41.4M | -$69.3M | -$110.8M | -$158.1M | -$291.2M | -$558.2M | -$892.0M | -$1.15B | -$1.33B | -$1.56B |
| Capitaux Propres | -$41.1M | -$68.7M | $86.8M | $345.4M | $860.8M | $663.3M | $436.2M | $265.8M | $150.3M | $157.4M |
| Dette Totale | $185000 | $10.1M | 0 | $1.9M | $77.4M | $179.9M | $187.7M | $181.6M | $70.3M | $159.2M |
| Dette Nette | -$9.4M | $8.7M | -$88.3M | -$334.5M | -$891.6M | -$551.6M | -$291.2M | -$103.9M | -$97.7M | -$50.7M |
| Fonds de Roulement | $7.7M | -$7.6M | $85.6M | $327.5M | $940.6M | $670.1M | $433.5M | $247.6M | $146.4M | $169.3M |
Santé financière
| Dette / Capitaux propres | 1.57 |
| Ratio de liquidité | 2.49 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -3.23 |
Rentabilité
| Rentabilité des capitaux propres | -273.23% |
| Rentabilité du capital investi | -115.23% |
| Rentabilité des actifs | -94.23% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ANAB · BBOT · EYPT · NRIX · OCS · PHAT · PROK
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de KOD: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions